Mass-Production Launch of Order-Backed Products at Hungarian Subsidiary
First written in FY2016-Q3. 3 of 4 entries say "Restated". Latest entry: FY2017-Q3.
0 other companies' latest entry also says "Restated".
- FY2017-Q3RestatedAnnual report
「In Europe, revenue was ¥16.390 billion (up ¥10.754 billion year on year, or 190.8%), mainly due to firm sales by the Hungarian subsidiary and the newly consolidated subsidiaries in Italy and Spain.」
Firm sales by the Hungarian subsidiary continue to be cited as a factor in European performance. - FY2017-Q2RestatedAnnual report
「In Europe, revenue was ¥10.561 billion (up ¥6.820 billion year on year, or 182.4%), mainly due to firm sales by the Hungarian subsidiary and the newly consolidated subsidiaries in Italy and Spain. Operating profit was ¥119 million, compared with an operating loss of ¥36 million in the same period of the previous year.」
Firm sales by the Hungarian subsidiary continue to be cited as a factor in European performance. Across Europe, the consolidation of the Italian and Spanish subsidiaries also contributed, and operating profit turned positive. - FY2016RestatedAnnual report
「The Hungarian subsidiary began full-scale mass production of products previously ordered, among other factors」
The start of mass production at the Hungarian subsidiary is cited as an ongoing driver of growth in European sales. However, the European operating loss was ¥209 million due to higher costs associated with winning new orders. - FY2016-Q3First statedAnnual report
「The Hungarian subsidiary began full-scale mass production of products previously ordered, among other factors」
The company explains that the start of mass production led to higher European revenue and a reduction in the operating loss.